Telos Biotech

Telos Biotech, a Cambrian Bio PipeCo, empowers innovative cell therapy companies to deliver on their promise: to cure the most severe, treatment-resistant cancers and bring these therapies to the patients that need them most. Our mission is to overcome cell aging and replicative lifespan limits caused by critically short telomeres. We aim to improve state-of-the-art cell and gene therapies by generating more biologically fit cells. We are developing a safe and state-of-the-art platform to overcome the manufacturing bottlenecks of cell therapies for optimal treatment outcomes. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.